ADC Therapeutics SA (ADCT) vs Eledon Pharmaceuticals (ELDN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Eledon Pharmaceuticals (ELDN) has outperformed ADC Therapeutics SA (ADCT) over the past year, losing 11.4% versus a loss of 67.1%. Over five years, ELDN leads with a -57.0% price change compared with -94.4% for ADCT. Eledon Pharmaceuticals is the larger company by market cap ($196.7 million vs $181.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ADCT | ELDN |
|---|---|---|
| Share price | $1.42 | $2.42 |
| Market cap | $181.29M | $196.65M |
| 1-day change | +11.81% | -1.22% |
| YTD return | -59.77% | +60.26% |
| 1-year return | -67.05% | -11.36% |
| 5-year return | -94.42% | -57.02% |
| EPS (TTM) | $-0.67 | $-0.89 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.98 | $4.60 |
| 52-week low | $0.78 | $1.35 |
| Distance from 52-week high | -71.49% | -47.39% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +134.51% | +271.90% |
| Average volume | 1.34M | 949.99K |
| Shares outstanding | 127.67M | 81.26M |
| Employees | 188 | 33 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ELDN has outperformed ADCT by 55.7 percentage points over the past year.
About ADC Therapeutics SA
ADCT stock →ADC Therapeutics SA provides antibody drug conjugate (ADC) technology platform in Switzerland and the United States. Its flagship product includes ZYNLONTA, a CD19-directed ADC, received accelerated approval from the U.S.
Healthcare · Drug Manufacturers - Specialty & Generic · 188 employees
About Eledon Pharmaceuticals
ELDN stock →Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company.
Healthcare · Biotechnology · 33 employees
ADCT vs ELDN FAQ
Which is bigger, ADC Therapeutics SA or Eledon Pharmaceuticals?
Eledon Pharmaceuticals (ELDN) is larger, with a market capitalization of $196.65M compared with $181.29M for ADC Therapeutics SA (ADCT).
Which stock has performed better over the past year, ADCT or ELDN?
ELDN returned -11.36% over the past 12 months, compared with -67.05% for ADCT (price return, excluding dividends). Past performance does not predict future results.
Are ADC Therapeutics SA and Eledon Pharmaceuticals in the same industry?
Both are in the Healthcare sector, but in different industries: Drug Manufacturers - Specialty & Generic for ADC Therapeutics SA and Biotechnology for Eledon Pharmaceuticals.